2022, Number 08
<< Back Next >>
Ginecol Obstet Mex 2022; 90 (08)
Vulvar basal cell carcinoma: A case report and review of the literature
Luque-González P, Pineda-Mateo M, Valle Aguilar-Martin, Rodríguez-Gómez R, Gutiérrez-Domínguez Á
Language: Spanish
References: 20
Page: 688-694
PDF size: 266.07 Kb.
ABSTRACT
Background: Basal cell carcinoma, or basal cell carcinoma, is the most common
nonmelanocytic skin neoplasm in Caucasians. Most of these neoplasms occur on photo
exposed skin (almost 85% on the head and neck). Vulvar involvement has a frequency
of no more than 1% to 2% of all basal cell carcinomas.
Objetive: To report a case of basal cell carcinoma of vulvar location and to review
the literature of recent years.
Clinical case: 74-year-old patient, with no personal history of interest, with an asymptomatic
vulvar lesion, with several months of evolution. On genital examination, a
3 cm lesion was found on the left labium majus, pale, non-ulcerated, raised, and stony.
The biopsy of the lesion reported: accessory breast tissue. In view of this report, it was
decided to excise the lesion and leave a surgical margin of approximately 1 cm. The
operation and postoperative period went smoothly. The anatomopathological study of
the surgical specimen reported that it was an ulcerated basal cell carcinoma, nodular
and superficial, with free resection margins. At two months post-surgical follow-up,
the patient was found to be in good condition, asymptomatic.
Conclusions: Although basal cell carcinoma is a very frequent neoplasm, vulvar
involvement is very rare. Diagnosis and treatment should be interdisciplinary, with the
collaboration of dermatologists and gyneco-oncologists.
REFERENCES
Salerni G, Bertania C, Celoria M, Lombardo S, Gorosito M,Fernández-Bussy RA. Dermoscopy of pigmented vulvarbasal cell carcinoma. Dermatol Pract Concept 2019; 9 (3):
239-40. https://doi.org/10.5826/dpc.0903a202. Namuduri RP, Lim TY, Yam PK, Gatsinga R, Lim Tan SK, et al.Vulvar basal cell carcinoma: clinical features and treatmentoutcomes from a tertiary care centre. SMJ 2019; 60 (9):479-82. https://doi.org/10.11622/smedj.2019014
McEnery-Stonelake M, Clark MA, Vidimos AT. Vulvar basalcell carcinoma arising in the setting of repeated perilampexposure. JAAD Case Rep 2020; 6 (2): 103-5. https://doi.org/10.1016/j.jdcr.2019.11.001
Dumont-Vieira GSO, Gonçalves-Rebelo AM, Miranda-Correia G, Monteiro Neiva Eulálio Filho W, et al. Carcinomade células basales de la vulva: una presentación rara deuna enfermedad común. Ginecol Obstet Mex 2018; 86 (4):267-71. https://doi.org/10.24245/gom.v86i3
Wohlmuth C, Wohlmuth-Wieser I. Vulvar malignancies: aninterdisciplinary perspective. J Dtsch Dermatol Ges 2019;17 (12): 1257-76. https://doi.org/10.1111/ddg.13995
Dumont Vieira GO, Gonçalves Rebelo AN, Miranda CorreiaG, Eulálio Filho WNM et al. Carcinoma de células basales dela vulva: una presentación rara de una enfermedad común.Ginecol Obstet Mex. 2018 abril;86(4):267-271. https://doi.org/10.24245/gom.v86i3
Cinotti E, Tonini G, Perrot JL, Habougit C, et al. Dermoscopicand reflectance confocal microscopy features of two cases ofvulvar basal cell carcinoma. Dermatol Pract Concept. 2018Jan 31;8(1):68-71. https://doi.org/10.5826/dpc.0801a17
Capria A, Tahir N, Fatehi M. Vulva cancer. StatPearls [Internet].Treasure Island (FL): StatPearls Publishing, 2021Jan. PMID: 33620867
Pleunis N, Schuurman MS, Van Rossum MM, Bulten J,etal. Rare vulvar malignancies; incidence, treatment andsurvival in the Netherlands. Gynecol Oncol. 2016; 142(3): 440-5. https://doi.org/10.1016/j.ygyno.2016.04.021
Renati S, Henderson C, Aluko A, Burgin S. Basal cell carcinomaof the vulva: a case report and systematic review ofthe literature. Int J Dermatol 2019; 58 (8): 892-902. https://doi.org/10.1111/ijd.14307
Villarreal Parra I, Rodríguez Mena A, Huerta Franco B, QuiñonesQuintero AG. Carcinoma basocelular en genitales:experiencia de 20 años. Comunicación de tres casos y revisiónde 309 casos. Dermatol Rev Mex 2012; 56 (5): 291-98.
Watson GA, Kelly D, Prior L, Stanley E, et al. An unusual caseof basal cell carcinoma of the vulva with lung metastases.Gynecol Oncol Rep. 2016 Oct 25;18:32-35. https://doi.org/10.1016/j.gore.2016.10.005
Flipo R, Bani MA, Rejaibid S, Talhi N, et al . Vulvar BasalCell Carcinoma: Clinical and Histopathologic Features. IntJ Gynecol Pathol. 2021 Mar 23.https://doi.org/10.1097/PGP.0000000000000771
Dalton AK, Wan KM, Gomes D, Wyatt JM,et al. Inguinalmetastasis from basal cell carcinoma of the vulva. CaseRep Oncol. 2019 Jul 23;12(2):573-580. https://doi.org/10.1159/000501769
De Giorgi V, Scarfi F, Gore A, Maida P, et al. Commenton: Vulvar basal cell carcinoma: clinical features andtreatment outcomes from a tertiary care centre. SingaporeMed J. 2020 Mar;61(3):167. https://doi.org/10.11622/smedj.2020032
Piva de Freitas P, Galusni Senna C, Tabai M, TakahiroChone C,et al. Metastatic basal cell carcinoma:a rare manifestation of a common disease. CaseRep Med. 2017 Nov 27; 2017: 8929745. https://doi.org/10.1155/2017/8929745
Bichakjian C, Aasi S, Alam M, Andersen J, et al. Basal CellSkin Cancer, Version 1, NCCN Clinical Practice Guidelinesin Oncology. J Natl Compr Canc Netw. 2019;14(5):574–97.https://doi.org/10.6004/jnccn.2016.0065
Sinha K, Abdul-Wahab A, Calonje E, Craythorne E, et al.Basal cell carcinoma of the vulva: treatment with Mohs micrographicsurgery. Clin Exp Dermatol. 2019 Aug;44(6):651-653. https://doi.org/10.1111/ced.13881
Calderón-Ponce de León Y, Torres-González S, Medina-Bojórquez A. Algoritmo de decisiones para el manejoquirúrgico del carcinoma basocelular. Dermatol Rev Mex 2020; 64 (4): 456-461.
Froeding LP, Hogdall C, Kristensen E, Mathiesen O, MortensenJ, Schnack TH. Recurrence and survival rates innode negative patients after sentinel node biopsy forearly-stage vulva cancer- a nationwide study. GynecologicOncology 2020; 156 (1): 124-30. https://doi.org/10.1016/j.ygyno.2019.10.024